Detalhe da pesquisa
1.
Prostate Cancer Screening With PSA, Kallikrein Panel, and MRI: The ProScreen Randomized Trial.
JAMA;
331(17): 1452-1459, 2024 05 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38581254
2.
Somatic Tumor Testing in Prostate Cancer: Experience of a Tertiary Care Center Including Pathologist-Driven Reflex Testing of Localized Tumors at Diagnosis.
Mod Pathol;
37(6): 100489, 2024 Apr 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38588883
3.
Predicting non-muscle invasive bladder cancer outcomes using artificial intelligence: a systematic review using APPRAISE-AI.
NPJ Digit Med;
7(1): 98, 2024 Apr 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38637674
4.
MRI-guided Focused Ultrasound Focal Therapy for Intermediate-Risk Prostate Cancer: Final Results from a 2-year Phase II Clinical Trial.
Radiology;
310(3): e231473, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38441092
5.
Papillary renal neoplasm with reverse polarity is biologically and clinically distinct from eosinophilic papillary renal cell carcinoma.
Pathol Int;
74(4): 222-226, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38456605
6.
Intraductal Prostate Cancer Affinity for Lymphatic-Predominant Metastases Through 18F-DCFPyLâProstate-Specific Membrane AntigenâPositron Emission Tomography/CT Scans in Pretreatment Prostate Cancer Patients.
J Urol;
211(4): 586-593, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38299501
8.
Addition of cribriform pattern 4 and intraductal prostatic carcinoma into the CAPRA-S tool improves post-radical prostatectomy patient stratification in a multi-institutional cohort.
J Clin Pathol;
2024 Feb 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38378247
9.
International Society of Urological Pathology Consensus Conference on Current Issues in Bladder Cancer: Main Conclusions and Recommendations.
Eur Urol;
85(5): 411-413, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38413300
10.
Using active surveillance for Gleason 7 (3+4) prostate cancer: A narrative review.
Can Urol Assoc J;
18(4): 135-144, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38381936
11.
Aggressive prostatic adenocarcinoma with urothelial-like morphology, with frequent CK7/CK20/HMWK expression and occasional diffuse neuroendocrine features: A clinicopathologic study of 12 cases.
Pathol Res Pract;
254: 155105, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38218041
12.
International Society of Urological Pathology (ISUP) Consensus Conference on Current Issues in Bladder Cancer: Progresses and Challenges.
Am J Surg Pathol;
48(1): 1-3, 2024 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37288838
13.
International Society of Urological Pathology Consensus Conference on Current Issues in Bladder Cancer. Working Group 4: Molecular Subtypes of Bladder Cancer-Principles of Classification and Emerging Clinical Utility.
Am J Surg Pathol;
48(1): e32-e42, 2024 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37199442
14.
International Society of Urological Pathology (ISUP) Consensus Conference on Current Issues in Bladder Cancer. Working Group 1: Comparison of Bladder Cancer Grading System Performance.
Am J Surg Pathol;
48(1): e1-e10, 2024 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37246824
15.
Proposal for a Novel Histological Scoring System as a Potential Grading Approach for Muscle-invasive Urothelial Bladder Cancer Correlating with Disease Aggressiveness and Patient Outcomes.
Eur Urol Oncol;
7(1): 128-138, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37562993
16.
International Society of Urological Pathology (ISUP) Consensus Conference on Current Issues in Bladder Cancer. Working Group 2: Grading of Mixed Grade, Invasive Urothelial Carcinoma Including Histologic Subtypes and Divergent Differentiations, and Non-Urothelial Carcinomas.
Am J Surg Pathol;
48(1): e11-e23, 2024 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37382156
17.
International Society of Urological Pathology (ISUP) Consensus Conference on Current Issues in Bladder Cancer: Working Group 3: Subcategorization of T1 Bladder Cancer.
Am J Surg Pathol;
48(1): e24-e31, 2024 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37737692
18.
Limitations of Prostate Biopsy in Detection of Cribriform and Intraductal Prostate Cancer.
Eur Urol Focus;
10(1): 146-153, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37696743
19.
Addition of Cribriform and Intraductal Carcinoma Presence to Prostate Biopsy Reporting Strengthens Pretreatment Risk Stratification Using CAPRA and NCCN Tools.
Clin Genitourin Cancer;
22(1): 47-55, 2024 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37558528
20.
Head-to-head: how many categories for grading urothelial carcinoma?
Histopathology;
84(3): 421-428, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37936516